marijuana stocks

Cara Therapeutics to Webcast Presentation at the Piper Jaffray 27th Annual Healthcare Conference

Cara Therapeutics, Inc. (CARA), a biotechnology company focused on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectively targeting kappa opioid receptors, today announced that Dr. Derek Chalmers, President and CEO, will present at the Piper Jaffray 27thAnnual Healthcare Conference on Wednesday, December 2, 2015, at 2:30 p.m. ET in New York City.

A live webcast of the presentation can be accessed under “Events and Presentations” in the News & Investors section of the Company’s website at www.CaraTherapeutics.com. An archived webcast recording will be available on the Cara website for approximately 30 days.

About Cara Therapeutics

Cara Therapeutics is a clinical-stage biotechnology company focused on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectively targeting kappa opioid receptors. Cara is developing a novel and proprietary class of product candidates that target the body’s peripheral nervous system and have demonstrated efficacy in patients with moderate-to-severe pain without inducing many of the undesirable side effects typically associated with currently available pain therapeutics.

Contact:
INVESTOR CONTACT:
Jesse Baumgartner
Stern Investor Relations, Inc.
212-362-1200
Jesse@sternir.com
MEDIA CONTACT:
Annie Starr
6 Degrees
973-415-8838
astarr@6degreespr.com

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

$NEWC Announces their Sannabis Indica Essential Oil and Pure Extract

New Colombia Resources, Inc. Announces their Sannabis Indica Essential Oil and Pure…

$CBIS Signs Gary Blick, MD and Proceeds With CS-TATI-1 for HIV

Cannabis Science Signs Gary Blick, MD and Proceeds With CS-TATI-1 for HIV…

Tilray, Inc. (TLRY) Releases 11 Million Shares From Lock-Up Agreement

Tilray, Inc. Releases 11 Million Shares From Lock-Up Agreement Tilray, Inc. (NASDAQ:…

Namaste Technologies Inc. (NXTTF) Signs Product Acquisition Agreement with AgMedica Bioscience Inc

Cannmart Signs Product Acquisition Agreement with AgMedica Bioscience Inc Namaste Technologies Inc.…